← Browse by Condition
Medical Condition
mycobacterium avium complex pulmonary disease
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 4
ClinicalMetric tracks all active clinical trials for mycobacterium avium complex pulmonary disease sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 4 3
Top Sponsors
3 trials
1 trial
NCT05906316
Recruiting
A Prospective, Multicenter, Single-arm MAC-PD Cohort: a NTM-NET and ESGMYC Collaborative Study
Enrollment
100 pts
Location
United States, Belgi...
Sponsor
Radboud University Medical Cen...
NCT07174076 Phase 4
Recruiting
Prevention of Recurrence With Cordyceps Sinensis in Mycobacterium Avium Complex Pulmonary Disease
Enrollment
300 pts
Location
China
Sponsor
Bin Cao
NCT07084402 Phase 4
Recruiting
Short-term Bactericidal Effect of Contezolid in MAC-PD
Enrollment
188 pts
Location
China
Sponsor
Bin Cao
NCT07213765 Phase 4
Recruiting
Short-term Antibiotic Therapy in Mycobacterium Avium Complex Pulmonary Disease
Enrollment
188 pts
Location
China
Sponsor
Bin Cao
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology